Recent Articles

• MannKind Corporation Releases Impressive Q2 2025 Financials
• Sunoco LP Delivers Strong Q2 Performance, Shows Growth
• Air Canada's New Points System: A Game Changer for Travelers
• MannKind Secures $500 Million Financing to Drive Growth Forward
• PUDO Inc. Expands Its E-Commerce Network with Annex Brands
• Blue Sky Uranium Corp. Enhances Exploration at Corcovo Project
• Compugen Achieves Key Progress in Ovarian Cancer Trials
• Pyxus International, Inc. Posts Q1 Fiscal 2026 Financials
• Taboola's Q2 Success: Financial Growth and Optimism Ahead
• Inventus Mining Achieves Impressive Gold Grades at Pardo
• Revolutionizing Autonomous Freight: PlusAI and Goodyear Team Up
• Parsons Corporation Delivers Strong Q2 Results Amid Growth
• White Gold Corp. Kicks Off Strategic Exploration Drilling
• Myrtle.ai Enhances ML Inference with Microsecond Latencies
• Dizal's Innovative Cancer Treatment Receives FDA Fast Track Status
• OMass Therapeutics Welcomes Carol A. Schafer as Director
• Legal Firms Investigate Major Losses in Bond Fund Investments
• Coda Octopus Group Earns ISO:17025 Accreditation in Calibration
• Claire's Takes Steps for Financial Recovery and Resilience
• Mingteng International Forms Strategic Alliance to Advance EV Market
• Formula Raw Launches Major Facility for Premium Pet Food
• Trident Resources Initiates Major Gold Drill Program at Contact Lake
• Pyxus International, Inc. Posts Q1 FY2026 Performance Insights
• Dayforce Inc. Sees Strong Growth in Q2 2025 Financials
• Bayes Market Secures $2 Million to Transform Prediction Industry
• Telesat Updates on Q2 2025 Financial Performance Insights
• Innovative Zenos Wellness Summit to Revolutionize Health
• Churchill Resources Reports High-Grade Antimony and Gold Findings
• Zenos Health Summit: A New Era for Wellness in the Middle East
• Discovering the Promise of BXCL501 in Treating Stress-Related Disorders
• Entrada Therapeutics Unveils Q2 2025 Results and Future Goals
• Energous Corporation's Strategic Stock Split Strategy Unveiled
• Verrica Pharmaceuticals Announces Second Quarter Updates
• Harrow's Participation Highlights at Annual Ophthalmology Conference
• Capital City Bank Achieves Record Ranking Among Best Companies
• Join the Conversation: Stella-Jones Second Quarter Results Call
• Kamada Ltd. Prepares to Share Q2 and H1 Financial Insights
• EyePoint Pharmaceuticals Shares Q2 Financial Performance Insights
• Insights into American Shared Hospital Services Financial Call
• NewAmsterdam Pharma's Latest Insights and Financial Performance
• Navigating the Recent Shift in XRP Prices: What to Expect
• Innovative Food Holdings to Discuss Second Quarter Results Soon
• AMD Faces Pre-Market Decline Amid Mixed Q2 Earnings Report
• BioCryst Pharmaceuticals Expands Workforce with Stock Options
• Sprott's Financial Performance Shows Strong Growth in Q2 2025
• New Silver Income Fund Achieves Top 10 Ranking Recognition
• Capital Square's New Build-For-Rent Community Acquisition
• Purple Biotech's Exciting Progress and Financial Insights
• Planet Fitness Reports Significant Revenue Growth in 2025
• Brookfield Asset Management Outperforms Expectations Once Again